Prelude Capital Management, LLC Vapotherm Inc Transaction History

Prelude Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.52 - $14.42 $53,585 - $306,626	-21,264 Reduced 26.92%	57,720 $146,000
Q1 2022 May 16, 2022	BUY	$12.69 - $20.72 $1 Million - $1.64 Million	78,984 New	78,984 $1.1 Million
Q4 2020 Feb 16, 2021	SELL	$23.44 - $31.85 $7,032 - $9,555	-300 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$25.1 - $53.8 $7,530 - $16,140	300 New	300 $9,000
Q2 2020 Aug 14, 2020	SELL	$16.0 - $40.99 $8,272 - $21,191	-517 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$7.79 - $19.91 $22,933 - $58,615	-2,944 Reduced 85.06%	517 $10,000
Q4 2019 Feb 14, 2020	SELL	$8.01 - $12.48 $15,803 - $24,623	-1,973 Reduced 36.31%	3,461 $42,000
Q3 2019 Nov 14, 2019	BUY	$8.7 - $23.46 $47,275 - $127,481	5,434 New	5,434 $51,000

1.29M

Ticker VAPO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,697,200
Market Cap $57.9M
Description
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.